Gastric Cancer

, Volume 16, Issue 2, pp 183–184

Erratum to: Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study

  • Kensei Yamaguchi
  • Akira Sawaki
  • Toshihiko Doi
  • Taroh Satoh
  • Yasuhide Yamada
  • Yasushi Omuro
  • Tomohiro Nishina
  • Narikazu Boku
  • Keisho Chin
  • Yasuo Hamamoto
  • Hiroya Takiuchi
  • Yoshito Komatsu
  • Shigehira Saji
  • Wasaburo Koizumi
  • Yoshinori Miyata
  • Atsushi Sato
  • Eishi Baba
  • Takao Tamura
  • Takashi Abe
  • Atsushi Ohtsu
Erratum

DOI: 10.1007/s10120-012-0205-y

Cite this article as:
Yamaguchi, K., Sawaki, A., Doi, T. et al. Gastric Cancer (2013) 16: 183. doi:10.1007/s10120-012-0205-y

Erratum to: Gastric Cancer DOI 10.1007/s10120-012-0167-0

In Table 5, the column headings “Grade 3” should be “Grade 3 or 4”.

The corrected table is shown here.
Table 5

Summary of adverse events

 

AVAGASTa (N = 94)

ToGAb (N = 50)

Total (N = 144)

All grades

Grade 3 or 4

All grades

Grade 3 or 4

All grades

Grade 3 or 4

N (%)

N (%)

N (%)

N (%)

N (%)

N (%)

Total

94 (100)

71 (76)

50 (100)

36 (72)

144 (100)

107 (74)

Hematological toxicities

 Neutropenia

63 (67)

45 (48)

34 (68)

20 (40)

97 (67)

65 (45)

 Thrombocytopenia

19 (20)

2 (2)

8 (16)

3 (6)

27 (19)

5 (3)

 Anemia

16 (17)

10 (11)

11 (22)

8 (16)

27 (19)

18 (13)

 Febrile neutropenia

5 (5)

5 (5)

3 (6)

3 (6)

8 (6)

8 (6)

Non-hematological toxicities

 Nausea

84 (89)

18 (19)

44 (88)

7 (14)

128 (89)

25 (17)

 Vomiting

60 (64)

6 (6)

28 (56)

2 (4)

88 (61)

8 (6)

 Diarrhea

51 (54)

4 (4)

24 (48)

2 (4)

75 (52)

6 (4)

 Stomatitis

34 (36)

1 (1)

16 (32)

1 (2)

50 (35)

2 (1)

 Abdominal pain

12 (13)

1 (1)

3 (6)

15 (10)

1 (<1)

 Hand-foot syndrome

54 (57)

2 (2)

23 (46)

1 (2)

77 (53)

3 (2)

 Rash

19 (20)

5 (10)

24 (17)

 Anorexia

83 (88)

27 (29)

46 (92)

10 (20)

129 (90)

37 (26)

 Fatigue

69 (73)

5 (5)

26 (52)

4 (8)

95 (66)

9 (6)

 Peripheral neuropathy

28 (30)

2 (2)

10 (20)

38 (26)

2 (1)

 Renal impairment

17 (18)

3 (3)

27 (54)

44 (31)

3 (2)

 Increased lacrimation

2 (2)

1 (2)

3 (2)

aThe target population of the AVAGAST study was metastatic or inoperable locally advanced adenocarcinoma of the stomach or gastro-esophageal junction

bThe target population of the ToGA study was HER2-positive metastatic or inoperable locally advanced adenocarcinoma of the stomach or gastro-esophageal junction

We sincerely apologize for the errors.

Copyright information

© The International Gastric Cancer Association and The Japanese Gastric Cancer Association 2012

Authors and Affiliations

  • Kensei Yamaguchi
    • 1
  • Akira Sawaki
    • 2
  • Toshihiko Doi
    • 3
  • Taroh Satoh
    • 4
  • Yasuhide Yamada
    • 5
  • Yasushi Omuro
    • 6
  • Tomohiro Nishina
    • 7
  • Narikazu Boku
    • 8
  • Keisho Chin
    • 9
  • Yasuo Hamamoto
    • 10
  • Hiroya Takiuchi
    • 11
  • Yoshito Komatsu
    • 12
  • Shigehira Saji
    • 13
  • Wasaburo Koizumi
    • 14
  • Yoshinori Miyata
    • 15
  • Atsushi Sato
    • 16
  • Eishi Baba
    • 17
  • Takao Tamura
    • 18
  • Takashi Abe
    • 19
  • Atsushi Ohtsu
    • 20
  1. 1.Department of GastroenterologySaitama Cancer Center HospitalSaitamaJapan
  2. 2.Department of GastroenterologyAichi Cancer Center HospitalAichiJapan
  3. 3.Gastrointestinal Oncology DivisionNational Cancer Center Hospital EastChibaJapan
  4. 4.Department of Medical OncologyKinki University School of MedicineOsakaJapan
  5. 5.Department of Gastrointestinal OncologyNational Cancer Center HospitalTokyoJapan
  6. 6.Department of ChemotherapyTokyo Metropolitan Cancer and Infectious Diseases Center, Komagome HospitalTokyoJapan
  7. 7.Department of Internal MedicineNational Hospital Organization Shikoku Cancer CenterEhimeJapan
  8. 8.Department of GastroenterologyShizuoka Cancer CenterShizuokaJapan
  9. 9.Department of GastroenterologyJFCR Cancer Institute Ariake HospitalTokyoJapan
  10. 10.Department of Medical OncologyTochigi Cancer CenterTochigiJapan
  11. 11.Cancer Chemotherapy CenterOsaka Medical CollegeOsakaJapan
  12. 12.Third Department of Internal MedicineHokkaido University HospitalHokkaidoJapan
  13. 13.Department of Medical OncologySaitama Medical University International Medical CenterSaitamaJapan
  14. 14.Department of GastroenterologyKitasato University East HospitalKanagawaJapan
  15. 15.Department of GastroenterologySaku Central HospitalNaganoJapan
  16. 16.Department of Internal Medicine, Toyosu HospitalShowa University School of MedicineTokyoJapan
  17. 17.Department of Hematology and OncologyKyushu University HospitalFukuokaJapan
  18. 18.Division of Diabetes, Digestive, and Kidney Diseases, Department of Clinical Molecular MedicineKobe University Graduate School of MedicineHyogoJapan
  19. 19.Internal MedicineYamagata Prefectural Central HospitalYamagataJapan
  20. 20.Research Center for Innovative OncologyNational Cancer Center Hospital EastChibaJapan